|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/16/21 Biocept Inc. 10-Q 6/30/21 71:9.7M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 1.13M
2: EX-10.2 Material Contract HTML 259K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 29K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 28K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 23K
6: EX-32.2 Certification -- §906 - SOA'02 HTML 23K
13: R1 Document and Entity Information HTML 74K
14: R2 Condensed Balance Sheets HTML 98K
15: R3 Condensed Balance Sheets (Parenthetical) HTML 39K
16: R4 Condensed Statements of Operations and HTML 94K
Comprehensive Income/(Loss) (Unaudited)
17: R5 Condensed Statements of Shareholders' Equity HTML 119K
(Unaudited)
18: R6 Condensed Statements of Cash Flows (Unaudited) HTML 95K
19: R7 Condensed Statements of Cash Flows (Unaudited) HTML 41K
(Parenthetical)
20: R8 The Company, Business Activities and Basis of HTML 158K
Presentation
21: R9 Liquidity HTML 29K
22: R10 Sales of Equity Securities HTML 29K
23: R11 Fair Value Measurement HTML 35K
24: R12 Balance Sheet Details HTML 92K
25: R13 Leases HTML 201K
26: R14 Stock-Based Compensation HTML 156K
27: R15 Common Stock Warrants Outstanding HTML 62K
28: R16 Net Loss per Common Share HTML 46K
29: R17 Commitments and Contingencies HTML 26K
30: R18 Related Party Transactions HTML 27K
31: R19 Subsequent Events HTML 24K
32: R20 The Company, Business Activities and Basis of HTML 164K
Presentation (Policies)
33: R21 The Company, Business Activities and Basis of HTML 129K
Presentation (Tables)
34: R22 Fair Value Measurement (Tables) HTML 30K
35: R23 Balance Sheet Details (Tables) HTML 91K
36: R24 Leases (Tables) HTML 199K
37: R25 Stock-Based Compensation (Tables) HTML 158K
38: R26 Common Stock Warrants Outstanding (Tables) HTML 61K
39: R27 Net Loss per Common Share (Tables) HTML 44K
40: R28 The Company, Business Activities and Basis of HTML 57K
Presentation - Additional Information (Detail)
41: R29 The Company, Business Activities and Basis of HTML 39K
Presentation - Composition of Net Revenues
Recognized Disaggregated by Source (Detail)
42: R30 The Company, Business Activities and Basis of HTML 36K
Presentation - Composition of Net Revenues
Recognized Disaggregated by Nature (Detail)
43: R31 The Company, Business Activities and Basis of HTML 43K
Presentation - Summary of Third-Party Payers That
Represent More Than 10% of Total Net Revenues and
Total Net Accounts Receivable and Their Related
Percentage (Detail)
44: R32 Liquidity - Additional Information (Detail) HTML 68K
45: R33 Sales of Equity Securities - Additional HTML 67K
Information (Detail)
46: R34 Fair Value Measurement - Additional Information HTML 53K
(Detail)
47: R35 Fair Value Measurement - Assumptions Used for HTML 42K
Determining Fair Values of Common Stock Warrants
(Detail)
48: R36 Balance Sheet Details - Schedule of Fixed Assets HTML 68K
and Accrued Liabilities (Detail)
49: R37 Leases - Additional Information (Detail) HTML 135K
50: R38 Leases - Schedule of Right-Of-Use Lease Assets HTML 27K
(Detail)
51: R39 Leases - Schedule of Current Portion of Operating HTML 27K
and Finance Lease Liabilities (Detail)
52: R40 Leases - Schedule of Long-Term Portion of HTML 27K
Operating and Finance Lease Liabilities (Detail)
53: R41 Leases - Schedule of Lease Expense (Detail) HTML 31K
54: R42 Leases - Schedule of Remaining Future Minimum HTML 71K
Lease Payments for Finance and Operating Leases
(Detail)
55: R43 Leases - Supplemental Cash Flow Information HTML 28K
Related to Operating and Finance Leases (Detail)
56: R44 Stock-Based Compensation - Additional Information HTML 69K
(Detail)
57: R45 Stock-Based Compensation - Summary of Stock Option HTML 52K
Activity (Detail)
58: R46 Stock-Based Compensation - Assumptions Used for HTML 40K
Determining Fair Value of Stock Options Under
Black-Scholes Pricing Model (Detail)
59: R47 Stock-Based Compensation - Summary of RSU Activity HTML 47K
(Detail)
60: R48 Stock-Based Compensation - Effects of Stock-Based HTML 36K
Compensation Related to Equity Awards to Employees
and Non-employees on Condensed Statement of
Operations and Comprehensive Loss (Detail)
61: R49 Common Stock Warrants Outstanding - Summary of HTML 37K
Equity-Classified Common Stock Warrant Activity
(Detail)
62: R50 Common Stock Warrants Outstanding - Additional HTML 40K
Information (Detail)
63: R51 Net Loss per Common Share - Additional Information HTML 28K
(Detail)
64: R52 Net Loss per Common Share - Schedule of HTML 34K
Anti-Dilutive Securities Excluded from
Computations of Diluted Weighted-Average Shares
(Detail)
65: R53 Commitments and Contingencies - Additional HTML 30K
Information (Detail)
66: R54 Related Party Transactions - Additional HTML 44K
Information (Detail)
67: R55 Subsequent Events - Additional Information HTML 32K
(Detail)
69: XML IDEA XML File -- Filing Summary XML 127K
12: XML XBRL Instance -- bioc-10q_20210630_htm XML 2.19M
68: EXCEL IDEA Workbook of Financial Reports XLSX 89K
8: EX-101.CAL XBRL Calculations -- bioc-20210630_cal XML 167K
9: EX-101.DEF XBRL Definitions -- bioc-20210630_def XML 540K
10: EX-101.LAB XBRL Labels -- bioc-20210630_lab XML 1.28M
11: EX-101.PRE XBRL Presentations -- bioc-20210630_pre XML 937K
7: EX-101.SCH XBRL Schema -- bioc-20210630 XSD 205K
70: JSON XBRL Instance as JSON Data -- MetaLinks 341± 535K
71: ZIP XBRL Zipped Folder -- 0001564590-21-044664-xbrl Zip 307K
 | Download this Microsoft® Excel® .xlsx workbook |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/15/22 Biocept Inc. 10-Q/A 9/30/21 75:10M ActiveDisclosure/FA 11/16/21 Biocept Inc. S-8 11/16/21 3:185K ActiveDisclosure/FA 11/15/21 Biocept Inc. 10-Q 9/30/21 70:9.4M ActiveDisclosure/FA |